Compounds > 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione
Page last updated: 2024-12-08
1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione
Description
1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione is a **synthetic compound** that is not widely known or researched.
There is very little information available about this specific compound online, and it doesn't appear to be a commonly studied molecule. Therefore, it is difficult to determine its significance in research.
**Possible reasons for its lack of prominence:**
* **Novelty:** This compound might be a newly synthesized molecule, with limited research conducted on it.
* **Limited Applications:** It could be a compound with specific but limited applications in certain areas of research.
* **Lack of Published Data:** The research on this compound might not have been widely published, limiting its visibility.
**Important Note:** It's crucial to rely on reputable scientific databases and peer-reviewed publications for information about specific chemical compounds. Without more information, it is not possible to provide a definitive answer regarding the importance of this compound in research.
**If you have more context or details about this compound, please provide them, and I will do my best to assist you.**
1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione: hypoglycemic agent; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 197004 |
| SCHEMBL ID | 23295123 |
| MeSH ID | M0050837 |
Synonyms (11)
| Synonym |
|---|
| brn 0733524 |
| 1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione |
| butaglionamide |
| benzenesulfonamide, 4,4'-(4-butyl-3,5-dioxo-1,2-pyrazolidinediyl)bis- |
| 4,4'-(4-butyl-3,5-dioxo-1,2-pyrazolidinediyl)bisbenzenesulfonamide |
| butaglyonamide |
| 4-[4-butyl-3,5-dioxo-2-(4-sulfamoylphenyl)pyrazolidin-1-yl]benzenesulfonamide |
| 5-24-05-00408 (beilstein handbook reference) |
| 2603-23-8 |
| DTXSID60180675 |
| SCHEMBL23295123 |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.13
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 13.13 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.92 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |